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Anotace
C´ılem te´to pra´ce je na´vrh univerza´ln´ı programovatelne´ platformy pro regulaci
operon˚u s vyuzˇit´ım meˇrˇen´ı hladin metabolit˚u. V prvn´ı cˇa´sti je uveden prˇehled
mechanismu˚, ktere´ vyuzˇ´ıvaj´ı bakterie, spolecˇneˇ s alternativami ze synteticke´ bi-
ologie. Jednotlive´ role teˇchto mechanismu˚ jsou vysˇetrˇeny simulacemi fyzika´lneˇ
relevantn´ıch matematicky´ch model˚u. Ve druhe´ cˇa´sti jsou uvedeny vy´hody vyuzˇit´ı
meˇrˇen´ı metabolit˚u. Trˇet´ı cˇa´st je pak veˇnova´na syste´move´mu na´vrhu synteticky´ch
cˇa´st´ı vyuzˇ´ıvaj´ıc´ıch simulta´nn´ı transkripce-translace v prokaryotech a meˇrˇen´ı hladiny
metabolit˚u. V posledn´ı cˇa´sti te´to pra´ce je pro tyto cˇa´sti vytvorˇen a validova´n
obecny´ model.
Kl´ıcˇova´ slova: synteticka´ biologie, regulace operonu, simulta´nn´ı transkripce
a translace, RNA regulacˇn´ı elementy, Escherichia coli
Abstract
The goal of this thesis is to design a versatile and programmable operon regula-
tion platform using metabolic intermediate measurements. In the first part, the
regulatory mechanisms implemented by bacteria are reviewed, together with the
synthetic biology design alternatives. The roles of these mechanisms are investi-
gated using simulations of physically relevant mathematical models. In the second
part, the advantages of using the metabolic measurements are shown. The third
part is dedicated to systematic design of transcriptional-translational coupling de-
vices that regulate operon expression using metabolic measurements. In the last
section, a corresponding general model is developed and validated.
Keywords: synthetic biology, operon regulation, transcriptional-translational
coupling, RNA regulatory elements, Escherichia coli
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1 Introduction 1
1 Introduction
Utilization of cellular organisms for production of valuable compounds became
reality after the invention of different techniques for DNA synthesis and DNA
transfection into living cells. These methods, such as restriction digest for cutting
DNA at specific places, DNA ligation for joining of different DNA fragments,
and cell transfection for introduction of new DNA into cells have allowed genetic
engineering to become reality.
In 1977, Genentech, Inc., reported the production of the first human protein
made in bacteria, using a synthetic recombinant gene for the first time. Only
a year later, in 1978, the same company announced a successful production of
human insulin in a bacterium Escherichia coli [1]. In the treatment of diabetes,
this synthesized insulin replaced animal insulin, which was more difficult to obtain,
therefore more costly and which was causing undesired reactions in some patients.
This key moment has started a new age of biotechnology.
1.1 Genetic engineering
After these first accomplishments in genetic engineering, the potential of using
multiple genes to create new pathways for production of different compounds
from various substrates was soon discovered. With an increase in complexity,
the need for a better understanding of these networks emerged. This has been
shown by several cases where alterations, improving the product formation (such
as increasing the activity of product-forming enzymes) have only resulted in small
improvements in the product yields. These results could be expected, since most
of the changes that decrease cell fitness often cause the cell’s regulatory network to
divert resources back to processes contributing to cellular fitness [2]. Since almost
every process in the cell is strictly controlled and regulated, every disturbance in
this balance can have severe consequences.
Some methods to at least partially overcome these difficulties were developed,
such as Classical Strain Improvement (CSI). This method relies on random mu-
tagenesis causing genomic alterations, followed by an extensive screening in order
to identify phenotypes with desired improvements. Although this approach has
been widely used [3], mainly by industry, it has some major disadvantages [2].
First, the information why the strain is improved is not known (in some cases,
this information can be provided by sequencing of the altered genome). Second,
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the majority of introduced mutations are deleterious and therefore less efficient.
Third, this method doesn’t use the potential of using specialized genes from differ-
ent organisms. These drawbacks became the subject of a new field called metabolic
engineering.
1.2 Metabolic engineering
Metabolic engineering aims at intelligent design, based on an extensive knowledge
of the underlying metabolic network (i.e. the set of chemical reactions leading to
the formation of a product, as well as the genes coding for enzymes catalyzing
these reactions). This is often achieved by development of relevant mathematical
models and their analysis, pointing out parts of the network and its surroundings
that constrain the production of a target metabolite. The predictions from these
models are often used to find the optimal trade-offs between the cell’s ability to
produce desired substance and its ability to survive.
In order to achieve the optimal trade-off, not only the single genes, but also
the cell regulatory networks need to be targeted and engineered.
1.3 Synthetic biology
As metabolic engineering added a systematic approach and analysis to genetic
engineering, synthetic biology introduced another level to engineering of genetic
circuits and metabolic pathways. It aims to apply engineering principles, such
as standardization, modularity and reusability of all the parts used, ultimately
creating libraries of standardized well-characterized parts involved in the cell reg-
ulation.
Its focus is on creating genetic circuits or metabolic pathways de novo, explor-
ing new options and new designs which can’t be found in nature. This means an
extensive need for computational modeling, accompanied by understanding of all
the biological processes involved and the ability to synthesize new DNA parts at
a reasonable price.
1.4 Biotechnology industry
After more than 40 years of using methods of genetic and metabolic engineering
in development of commercial products, synthetic biology has begun to spread
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into commercial applications. One of the first industrial enterprises, which used
synthetic biology methods in their production, is the life sciences and materials
company DSM in optimizing its process of synthetic antibiotic cephalexin pro-
duction [4]. Although the number of biotechnology companies which have used
synthetic biology techniques to speed up and improve their research is growing,
full potential has yet to be realized.
1.5 Thesis objective
Joint regulation of multiple genes is realised by grouping the genes into clusters
called operons. At present, this is not easily programmable as it relies on ex-
isting regulatory pathways. The general objective of this thesis is to develop a
general programmable method for operon regulation using metabolic intermediate
measurements. The specific objectives are:
1. develop a model of the regulatory mechanism,
2. propose a set of validation experiments for the model and for the developed
regulatory mechanism,
3. validate the developed model.
The thesis is organized as follows: In Section 2, an overview of a model system
(trp operon), its regulatory mechanisms and design alternatives is presented. In
Section 3, different loop feedback designs and different controller inputs are com-
pared. In Section 4, a regulatory mechanism based on transcriptional-translational
coupling and its model is developed. In Section 5, the proposed model is validated.
Discussion and future work can be found in Section 6.
2 Metabolic pathway for the biosynthesis of L-
tryptophan
Bacteria use operons for the joint expression of enzymes catalyzing production
of essential metabolites. In this section the regulatory mechanisms implemented
by bacteria are reviewed. An excellent motivational example is the biosynthesis
of amino acid L-tryptophan in the bacterium E. coli, which was selected for the
following reasons:
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1. It has been extensively studied, both experimentally [5] and mathematically
[6].
2. It features three independent negative feedback loops (see Section 2.1). This
suggests that regulation is very important.
3. Since L-tryptophan is essential for the cell, but its synthesis is expensive
in terms of energy and nutrient requirements, these control mechanisms
and their structure have supposedly evolved to maintain proper intracellular
tryptophan concentration under various conditions [7] - therefore we expect
this pathway to be robustly regulated.
4. There is a need to jointly regulate expression of different genes coding for
the enzymes, as evidenced by the grouping of pathway genes in a single
operon1.
Below we will discuss the details of this pathway related to regulation, the
existing mathematical models of this pathway, and the design alternatives.
2.1 Biology and regulation
The tryptophan biosynthetic pathway consists of multiple steps, which are cat-
alyzed by the enzymes encoded in the trp operon (Fig. 1).
Figure 1: Scheme of the trp operon and tryptohan biosynthesis pathway.
1Operon can be defined as a group of genes, functionally related, being physically close to
each other and under one common control mechanism [8].
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Trp operon consists of five genes (trpE, trpD, trpC, trpB and trpA), which are
transcribed together, from left (trpE ) to right (trpA). This organization ensures
that enzymes needed at the beginning of the metabolic pathway are expressed
first.
Transcription of the operon is controlled by two different negative control
mechanisms - transcriptional repression and attenuation. Also, third negative
control mechanism is present in the form of allosteric enzymatic inhibition. A
schematica of the corresponding nested control loops is shown in Fig. 2.
trp genestrpL
Figure 2: Control mechanisms in the trp operon.
2.1.1 Transcriptional repression
Transcriptional repression is mediated by a dimeric repressor protein TrpR, en-
coded by the trpR gene. This gene is not adjacent to the operon, and its transcrip-
tion is controlled by a moderate promoter, also negatively regulated by TrpR [9].
When the tryptophan is present at low concentration in the cell, TrpR protein
is in an inactive form and cannot bind to the operator site of the trp operon (see
Fig. 3). This allows RNA polymerase to bind to the trp promoter and transcribe
the genes. This elevates the levels of enzymes in the metabolic pathway and in
turn increases the level of tryptophan in the cell. When the tryptophan concen-
tration is sufficient, the excess tryptophan binds noncooperatively to the TrpR
repressor (two molecules per one protein), causing allosteric change in the protein
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conformation and thus allowing the protein to bind to the operator [10]. When
the repressor protein is bound, the RNA polymerase cannot transcribe the genes,
decreasing corresponding in enzyme levels and causing tryptophan production to
decrease.
Figure 3: Repression mechanism in trp operon. Source: Wikimedia Commons,
file Trpoperon.svg
This mechanism regulates trp operon expression over approximately a 100-fold
range [11] and its strength depends on the intracellular concentration of trypto-
phan molecules [12].
Synthetic biology alternatives Negative feedback for the regulation of operon
expression may be introduced by expressing a repressor protein from one of the
genes in the operon. Specificity is determined by the fact that the produced
repressor must be able to recognize and bind to a specific sequence (called the
operator) in the promoter of the operon. This implicates that, when introducing
negative feedback, a specific tandem of promoter and repressor protein must be
used. Although there are some well characterized examples of these pairs com-
monly used in synthetic circuits (such as repressor protein LacI and promoter
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pLac promoter [13]), their set is quite limited. These limitations can be overcame
by the use of transcription activator-like effectors (TAL effectors or TALE).
TAL effectors were discovered in 2009 in Xanthomonas bacteria, which use
them while infecting various plant species [14]. The purpose of these proteins is
to modulate transcription of the host plant cells in order to promote bacterial
infection. Main feature of these TALEs is their central repeat domain, consisting
of typically 34 amino acid repeats.
Figure 4: Scheme of a TAL effector. Amino acids NI in the central repeat recognize
nucleotide adenin. Source: Freiburg 2012 iGEM wiki
This domain is able to recognize and bind specific DNA sequences, based on
the identity of two critical amino acids in each of these repeats. Since there is
a known relation between these two amino acids and recognized nucleotides (see
Fig. 4), these proteins can be easily engineered in order to bind to a DNA sequence
of our interest. As was shown by the Slovenian iGEM 2012 team [15] and many
other research groups, these proteins can be also engineered to work as repressors
and therefore can be used for introduction of a genetic negative feedback loop.
However, the use of general transcription factors has one disadvantage in com-
parison to regulation in the trp operon - the resulting feedback is not derived from
the final metabolite, but from the level of enzymes produced by this operon.
2.1.2 Attenuation
Transcriptional attenuation is a mechanism for premature termination of tran-
scription, based on the transcriptional-translational coupling. It has been found
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in a number of operons in E. coli and other prokaryotes [10]. It consists of a rela-
tively short sequence, located between promoter and the operon structural genes
(in the 5’ UTR).
In the trp operon, this sequence is a 162bp long leader region trpL (see Fig.
1) [5]. This leader region consists of four sequences, numbered 1 to 4 from left
to right. Since each sequence is partially complementary to the next one, three
different secondary structures (hairpins) can form on the transcribed RNA: 1-2,
2-3 and 3-4. However, the transcribed RNA can adopt only two conformations,
called termination and anti-termination:
• Termination conformation - in this case, structure 3-4 (terminator hair-
pin preventing transcription) is formed. This is possible only when the se-
quence 3 is not paired with sequence 2, i.e. sequence 2 is paired to sequence
1 or sequence 2 is sequestered by a ribosome.
• Anti-termination conformation - in this case, termination structure 3-4
is not formed. This is possible only when complex 2-3 is formed, i.e. when
sequence 2 is available and is not part of complex 1-2.
The final conformation depends on the intracellular concentration of trypto-
phan charged tRNA. It was discovered that the leader region contains an open
reading frame (ORF)2 [11], coding for a short polypeptide of 14 amino acids and
termed the leader peptide [16].
The mechanism by which attenuation regulates transcription is shown in Fig 5.
First, RNAP begins with a transcription of the leader region with sequences 1 and
2. Almost immediately after this sequence is transcribed, ribosome bounds and
begins with the translation of the produced RNA. If the tryptophan concentration
is low, ribosome stalls at sequence 1 with two consecutive Trp codons, blocking
the formation of complex 1-2 and thus forming the anti-termination conformation
(Fig. 5b).
Otherwise, if tryptophan concentration is high, the sequence 2 is sequestered
instead of sequence 1, so the terminator conformation is formed (Fig. 5a), prevent-
ing the transcription of the remaining operon genes. This mechanism regulates
trp operon expression over a 6 to 8-fold range [11].
2ORF denotes a region of nucleotides, bounded by the start and stop codon.
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Figure 5: Attenuation mechanism in trp operon. Source: Wikimedia Commons,
file Trp operon attenuation.svg
Synthetic biology alternatives The synthetic biology alternative to atten-
uators are transcriptional riboswitches. According to [17], transcriptional ri-
boswitches can be considered as a special class of attenuators, although some
authors consider riboswitches as a separate group. The main difference between
attenuators and riboswitches is in the sensing RNA element. In attenuators, this
part is a general element sensing a variety of inputs (e.g. proteins, temperature),
while in riboswitches, this part is called an aptamer that is bound by different
small molecules (called ligands). After the aptamer part, riboswitch consists of
an expression platform that performs a specific action upon a ligand binding (see
Fig. 6). This action can be the formation of an intrinsic terminator preventing
transcription, or formation of an anti-terminator that enables transcription of the
downstream genes.
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Figure 6: Mechanism of transcriptional riboswitches. In this case, upon a lig-
and binding to the aptamer, terminator is formed, thus transcription is stopped.
Original image taken from [18].
The discovery and characterization of these RNA-based regulatory elements
is dated to 2002, when the first comprehensive study was published [19]. Since
then, many natural riboswitches were discovered and a lot of work has been done
in the study of their mechanism.
The problem of engineering synthetic riboswitches can be generally3 divided
into two separate parts:
1. Aptamer design - practically all approaches to obtain a new aptamer
are based on a method called SELEX (systematic evolution of ligands by
exponential enrichment). This method involves generating of a large pool of
randomized RNA sequences (up to 1014), and their mixing with immobilized
target ligands. After washing, the bound sequences are eluted, amplified by
PCR4 and subjected to further round of this selection process. After each
iteration, aptamers with higher affinity (ability to bound the ligand) are
found [20].
3In some cases, aptamer itself can work as a sensing and regulatory domain.
4Polymerase chain reaction.
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2. Expression platform design - involves design of an RNA sequence, which
alters its secondary structure upon a ligand binding to the aptamer. There-
fore this sequence can be divided into two parts - module performing the
desired change in its secondary structure, and communication module, which
serves as an interlink between an aptamer and this module [21].
Unfortunately, there are some limitations in designing new riboswitches. First,
aptamers obtained by the SELEX procedure are aptamers that work in vitro.
However, they often show reduced or disabled functionality in live cells, mainly
due to a different concentration of Mg ions. Also, a little success has been achieved
in designing expression platforms for transcriptional riboswitches, due to more
complicated interactions in the produced RNA molecule. However, this situation
has began to change, since in 2013 some authors reported de novo design of a
synthetic riboswitches that regulates transcription termination [22], [23].
2.1.3 Enzymatic inhibition
The third regulation mechanism in the biosynthesis of tryptophan does not influ-
ence the process of transcription of the enzymes involved, instead it targets their
activity, specifically the activity of anthranilate synthase (AS), a heterotetramer
formed by two TrpE and two TrpD polypeptides [12]. This enzyme catalyzes the
first step of the pathway leading to the production of tryptophan. If the trypto-
phan concentration is high, it binds to the AS, causing allosteric inhibition of its
activity and therefore decreasing its production.
Synthetic biology alternatives Although significant advances are being made
in the field of protein engineering every year, to the author’s knowledge, no meth-
ods enabling design of new enzymes, or rational redesign of existing enzymes (in
order to introduce this kind of inhibition) exist. Current level of protein engi-
neering in synthetic biology involves increasing of the activity, altering protein
specificity and altering regulatory elements of proteins (mainly deleting allosteric
inhibition by destroying the specific site by site directed mutagenesis [24] or by
directed evolution) [25].
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2.2 Mathematical modeling
Several deterministic models have been developed to understand the trp operon
mechanisms of gene regulation. These models are based on different mathematical
methods and different levels of simplification, but only a few of them have also
considered attenuation (stating that the influence of attenuation is negligible; this
argument is based on the results from [26]). These models are presented in Table 1.
Table 1: Overview of deterministic trp operon models
Year, Author Typea Validated experimentallyb Reference
2001 Santilla´n DDE Yes [27]
2004 Santilla´n DDE Yes [12]
2004 Venkatesh ODE Yes [7]
2006 Bhartiya ODE Yes [6]
2008 Nguyen S-Systems Yes [10]
aDDE=delay differential equations; ODE=ordinary differential equations; for S-Systems,
see [28].
bInterestingly, all listed models were validated against experimental results presented
in [11], making a standard for trp operon modeling from this reference. However, as some
authors pointed out, the time step in dynamic measurements is so large that the dynam-
ics before reaching a steady-state is not well known and some models show considerable
discrepancies between their initial dynamics and these data [29].
Although all models were experimentally validated (see Table 1 for details),
some used parameters differed significantly across parameter sets. For example,
the dissociation constant value of 810μM for enzymatic inhibition used in model
by Venkatesh practically eliminated the influence of this negative feedback.
For this reason, authors of one of the most recent models have surveyed the
existing models, using the most reasonable value of each parameter [30]. Their
model, based on Bhartiya et al. [6], considers this set of reactions:
Ot −→ Op −→ ∅, (1)
Op −→ mRNA −→ ∅, (2)
mRNA −→ Enz −→ ∅, (3)
Enz −→ Trp −→ ∅. (4)
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These equations stand for the production and loss (i.e. degradation and dilu-
tion due to cell growth) of free operator (1), production and loss of mRNA from
the free operator (2), production and loss of anthranilate synthase from mRNA
(3) and production and consumption of tryptophan (4). To expand the model
capabilities, we added another reaction, representing tryptophan uptake from the
environment:
∅ −→ Trp. (5)
This set of reactions can be modeled using ODEs as follows:
dOp
dt
= k1
Kn11
Kn11 + T
n1
Ot − (kd1 + µ)Op, (6)
dM
dt
= k2
Kn22
Kn22 + T
n2
Op − (kd2 + µ)M, (7)
dE
dt
= k3M − (kd3 + µ)E, (8)
dT
dt
= k4
Kn33
Kn33 + T
n3
E + d
Text
e+ Text
(
1 + T
f
) − ( g
T +Kg
+ µ
)
T. (9)
Values of all used parameters are listed in Appendix A. It is also important to
note that because the level of tRNATrp is dependent on the level of tryptophan in
the cell, it is possible to use tryptophan concentration as controller inputs for all
three types of regulation (i.e., transcriptional repression, attenuation, allosteric
inhibition).
This model was validated by its authors, using experimental data from [11],
both for wild-type cells and different mutant strains. Authors reported and
demonstrated that this model confidently reflects the trp operon behavior.
3 Engineering operon regulation based on the
trp operon
Some important questions arise from the structure of tryptophan system. Many
engineering control strategies rely on sophisticated and intense computational al-
gorithms to achieve robustness. But cellular organisms have to rely only on simple
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chemical interactions. One of the questions, which many authors [6], [7] asked dur-
ing the study of the trp operon, is why nature uses three different feedback loops
instead of one. Is this design somehow advantageous? If so, could this motif be
transferred to other biological or engineering applications?
3.1 Single versus nested loop feedback design
Bhartiya et al. answered this question by comparing two different designs of the
trp operon system, conceptualizing the system as three processes in series (see
Fig. 7). First design involved all three negative feedback loops (repression, atten-
uation and inhibition) while the second one used a single feedback loop strategy
(repression). We will refer to these designs as nested feedback loop (NFL) and
single feedback loop (SFL). Note different names are used in [7].
a)
b)
P1 P2 P3
C1
C2
C3
P1 P2 P3
T
C1
T
Figure 7: Schematic of designs used for the comparison of NFL and SFL. Processes
P1, P2 and P3 represent transcription, translation and tryptophan synthesis, re-
spectively. a) NFL with genetic regulation (C1), transcriptional attenuation (C2)
and enzyme inhibition (C3). b) SFL with genetic regulation only.
Dynamic response of the tryptophan system must satisfy number of conditions.
Tryptophan concentration must be maintained in a very narrow range. In addi-
tion, short rise time is needed, accompanied with short settling time. Generally,
short rise time is associated with longer settling times and excessive overshoot.
Assuming that tryptophan system has evolved for efficient cellular functioning,
the authors in [6] introduced a simple metric to capture the deviances from the
wild-type response:
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I(p, s) =
1√
tf
√∫ tf
0
[T (t, p, s)− T ∗(t)]2 dt, (10)
where T ∗(t) is the wild-type response at time t. Using this metric, the au-
thors searched for optimal SFL parameter values realted to genetic regulation
(i.e., cooperativity constant n1 and dissociation constant K1). Figure 8 shows the
resulting plot showing the outputs (tryptophan concentration) of wild-type NFL
and the optimized SFL design.
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Figure 8: Comparison of NFL and SFL of tryptophan system, as shown in [6].
Even with the altered parameters of genetic regulation, the SFL shows significantly
longer rise (trs) and settling times (tss) in comparison to NFL.
Even an optimally tuned SFL with the lowest value of I(p, s) cannot achieve
required response characteristics - the SFL rise time value of over 40 min is not
sufficient for the cell in order to survive.
This comparison was based on the model published by Venkatesh et al. [7],
using the original set of parameters. In addition, one of the two parameters
authors varied (n1) is practically impossible to tune in real systems. Therefore,
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we performed a new comparison using the model and the parameter set from
Section 2.2 and varying instead the rate of transcription k1 and the dissociation
constant K1. These two parameters are experimentally tunable by changing the
DNA sequence of the promoter. The results are shown in Fig. 9, where NFL is a
model of wild-type tryptophan system based from Section 2.2 and SFL represents
the tryptophan system with only transcriptional repression feedback, with altered
parameters k1 and K1 in order to achieve minimal value of the metric I(p, s). Over
500 000 different values of k1, each with 500 different values of K1 were evaluated
in this search.
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Figure 9: Comparison of NFL and SFL of tryptophan system, using the model
from this chapter. Parameters of genetic regulation in SFL were altered in order
to minimize the value of metric I(p, s). Again, significantly longer rise (trs) and
settling times (tss) were observed.
As we can see in Fig. 9, the performance of SFL based on the new model is
even worse, rise time of 80 min wouldn’t be enough for a cell to survive.
Motivated by the fact that transcriptional regulation is one of the basic and
most common regulatory mechanisms, we wanted to find its main advantage.
From the other two regulatory mechanisms in the trp operon, only enzymatic
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inhibition doesn’t work on transcriptional level. Therefore, we made another SFL
design using only the enzymatic inhibition, and used again the metric (10) in
order to optimize its dynamics.
As can be seen in Fig. 10, the performance of this design is the worst in terms
of the rise and settling times. But one important thing can be seen in Fig. 10,
when enzyme levels of the wild-type trp operon and two different SFL designs are
compared. For the same steady-state level of the target metabolite, a significantly
lower concentration of the enzymes is needed. This is due to the fact that in SFL
with transcriptional repression only, all the produced enzymes are active, while in
the wild-type tryptophan system and SFL with enzymatic inhibition a fraction of
the enzymes are always inhibited.
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Figure 10: Comparison of the dynamic of the wild-type trp operon system and two
different SFL designs that use transcriptional repression or enzymatic inhibition.
Overall, our simulations confirm the results from other authors [29], [10], [6],
that an optimal structural design has evolved in the tryptophan system in order
to meet necessary characteristics and that transcriptional or enzymatic regulation
alone cannot outperform the wild-type NFL design.
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3.2 Translational control as an alternative to transcrip-
tional regulation
One regulatory mechanism used in synthetic biology is not involved in the reg-
ulation of trp operon. This mechanism works on a translational level and is
implemented in form of translational riboswitches.
Translational riboswitches are based on the same principle as the riboswitches
controlling transcription. They also have an aptamer and expression platform (see
Sec. 2.1.2), which changes its conformation with ligand binding. The difference is
that translational riboswitches only sequestre or free an RBS site on the mRNA,
using usually simple pairing (see Fig. 11).
Figure 11: Mechanism of translational riboswitches. In this case, upon a ligand
binding to the aptamer, RBS is sequestered, thus the ribosome cannot bind and
begin with translation. Original image taken from [18].
Since no complex secondary structures are formed, the design of these elements
is simpler than that of transcriptional riboswitches [22], [31], and many artificial
riboswitches have been designed [21]. Disadvantage of their use in the control of
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gene expression in operons is that a full mRNA molecule is always produced. This
production generates unnecessary burden for the cell.
One disadvantage is that a single translational riboswitch can only regulate
translation of genes belonging to a single RBS (see Fig. 12). This regulation
is plausible for operons like the trp operon, where a single RBS controls all the
genes using codon overlapping (last nucleotide of the stop codon is also the first
nucleotide of the start codon (see Fig. 12) and [32]). The majority of existing
operons, however, are controlled by multiple RBSs, one for each gene [33].
Figure 12: a) Common structure of bacterial operon - every gene has its own RBS.
b) Operon with only one RBS for all genes (example is the trp operon). In this
case, one ribosome can translate all genes at once without leaving the mRNA.
When ribosome encounters stop codon, it also detects start codon, shifts frame
and begins to translate the next gene.
3.3 Choice of controller input
In order to investigate the difference between different controller inputs, a simple
model was made:
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dM
dt
= k1C1(E)− (kd2 + µ)M, (11)
dE
dt
= k3C2(P )M − µE, (12)
dP
dt
= k4E − µP . (13)
These equations refer to the transcription of mRNA (M) from an operon
(11) and production of an enzyme (E) (12) catalyzing the formation of a prod-
uct/metabolite(P) (13). Default values for all the parameters were taken from the
trp operon model and can be found in Appendix A. Functions C1(E) and C2(P )
were defined as
C1(E) =
Kn11
Kn11 + E
n1
, (14)
C2(P ) =
Kp
Kp + P
. (15)
Function C1 incorporates the effect of genetic repression by the produced en-
zyme, function C2 incorporates the effect of translational repression from a ri-
boswitch (therefore controller input to C2 is the metabolite concentration, whereas
controller input to C1 is the enzyme concentration). Parameters K1 and n1 were
again taken from Appendix A, parameter Kp was set to 10μM. Three different
designs were compared, using single controllers C1 or C2, or their combination.
In this comparison (Fig. 13), parameter k1 in the model with the controller
C1 was lowered to k1 = 3 min
−1. For other two models, parameters k1 and k3
were tuned in order to get the same steady-state level of the metabolite. These
parameters were chosen because they are easily tunable in real systems (promoter
and RBS strength, codon usage). Simulation time was 3 hours. At time t = 70
min, after all models reach their steady-state, parameter k4 was raised two times,
for a duration of one hour. This perturbation can be caused in real systems by
a sudden rise in a substrate concentration, an addition of a metabolite to the
medium or by a change in enzymatic activity.
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Figure 13: Comparison of three different synthetic designs for control of operons.
Repression is a design which uses only controller C1, riboswitch design includes
only the controller C2 and repression + riboswitch uses controllers C1 and C2.
All three designs show overshoot in their enzyme levels at the beginning. Upon
introduction of a change in parameter k4, we can observe that enzyme levels of
repression-only design haven’t changed. This was predicted, since the feedback
signal is not sensitive to metabolite concentration change as caused by the intro-
duced perturbation. The level of metabolite for this design is in accordance with
this behavior - new temporal steady state was three times higher.
Other two designs have a feedback derived directly from the metabolite lev-
els. As can been seen, the single riboswitch design outperforms the combined one
in terms of sensitivity to the introduced perturbation - riboswitch design shows
1.7-fold change in its metabolite steady-state, meanwhile combined design shows
2.3-fold change. This can be explained by the respective enzyme levels - although
these levels were lowered upon the induction, the combined design maintain higher
levels. This is due to the fact that in this design, when the perturbation is intro-
duced, the controller C2 acts to lower the level of the enzymes. This change in the
enzymatic concentration is noticed by the controller C1, which tries to compensate
for this loss.
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4 Transcription-translation coupling as a way of
controlling gene expression
In Section 3 it was shown that the designs with feedback on final metabolites
measurements outperforms feedback on enzymatic levels. From Section 2.1, we
know that the control elements using metabolite concentration as an controller
input are riboswitches. Since the transcriptional riboswitches are very difficult to
engineer, the only way now is to use translational riboswitches that are rationally
designable using the current knowledge of RNA interactions. However, as was
presented in Sec. 3.2, they are not able to control the transcription of the operon
mRNA (which can be over 10kbp5 long and its production from constitutive pro-
moter can be heavy burden for the cell). Also, introducing this riboswitch to
the RBS of every gene could significantly increase the experimental workload and
make their design harder (because of possible RNA interactions in the long tran-
script). Last, but very important thing is that these elements cannot be simply
linked together in order to form more complex regulatory networks.
The question we asked was, is there a way to overcome these limitations? Is
it possible to use the advantage of the simple design of translational riboswitches
and use them for a regulation on the transcriptional level?
From the study of the trp operon, we know about one mechanism that basi-
cally links together translational control with transcription - the attenuation (Sec.
2.1.2). In order the transcription to stop or continue, translation of the leader
peptide must be completed or interrupted. This phenomenon is based on the
transcription-translation coupling [34], [35], and is specific to prokaryotes, where
translation can begin practically immediately after the start of transcription.
4.1 Adaptors design based on the tna operon
The transcriptional-translational coupling for the control of the gene expression
has been already used by Liu et al. [31]. In this work, the authors developed
an adaptor for converting translational regulators into regulators of transcription,
based on the tna (tryptophanase) operon. This operon codes for the enzymes
involved in the tryptophan conversion. The transcription of this operon is con-
5kilo base pairs = 1000 nucleotides
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trolled by a rho-dependent terminator6 in the leader sequence tnaC. The RBS of
the tnaC is always active, which means that the leader region is being constantly
translated. If the level of tryptophan is sufficient, the ribosome is able to translate
the whole leader sequence. At the end of this sequence, the ribosome stalls at the
terminator, physically sequestering it, therefore allowing polymerase to transcribe
the coding genes. If the tryptophan concentration is low, ribosome is not able to
translate the leader sequence and reach the terminator in order to sequester it. In
this case, the transcription is terminated.
Authors hypothesized that replacing the native tnaC RBS with an RBS which
can be regulated in order to switch between ’on’ and ’off’ states could be the key to
the adaptor design. In the ’off’ state, the ribosome wouldn’t be able to even start
with the translation of the leader region, much less obstruct the terminator. In
the ’on’ state in the presence of a sufficient level of tryptophan, the leader region
would be translated and the terminator site sequestered. This hypothesis was
tested and proven, using different RNA elements and translational riboswitches
as the regulated RBS.
4.2 Adaptors design based on the trp operon
We have identified several disadvantages in the adaptors design based on the
tna operon. First, since the egineered adaptors are based on the original tnaC
sequence, sufficient levels of tryptophan must be present in order to block the
trasncription termination even if the RBS is in the ’on’ state. Second, while
designing more complex circuits such as NOR gates controlling the operon tran-
scription, one tnaC element must be used for every gate (Fig. 14a). This makes
the whole design also more complex. And third, the change of the native RBS
must be done in the tnaC element, which requires precise predictions of the sec-
ondary structures induced by these changes (Fig. 14b).
6This type of terminators needs a special protein, called Rho factor, to be bound in order to
terminate transcription.
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Figure 14: a) Scheme of a design with NOR gates controlling transcription of
the gfp gene. For every gate, one tna adaptor (grey) must be used together with
corresponding RNA element. b) Wild-type tnaC sequence on the left. On the
right is the tnaC sequence with an RNA element controlling RBS state. Notice
that for an introduction of an RBS control element, the changes must be done
inside the tnaC sequence. Images adopted from [31].
Therefore, we have designed our own adaptors, using the trp operon as an
inspiration. As was presented in Sec. 2.1.2, the attenuation in the trp operon is
based on the formation of an anti-termination or termination loop. This termina-
tion loop works as an intrinsic (rho-independent) terminator, therefore it doesn’t
need a Rho-factor to be present in order to terminate transcription.
Our goal was to design a new modular leader region, able to control the ex-
pression of the structural genes located downstream of this sequence. Assuming
that this leader region is right after the promoter, we first put an intrinsic ter-
minator at the beginning of this region. In a normal situation, this terminator
would stop the majority of bound RNA polymerases, therefore greatly reducing
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the rate of transcription. The ratio of the stopped RNAPs to all bound RNAPs is
called termination efficiency and is known for the characterized terminators (like
for the ones from the Registry of Standard Biological Parts [36]).
Based on the [37], where an extensive study of intrinsic termination was pub-
lished, we proposed a novel mechanism of regulation based on the transcriptional-
translational coupling. As in the adaptors by Liu et al., we introduced a trans-
lational control element with an RBS and a start codon at the beginning of the
leader region (before the intrinsic terminator). Also, we put a stop codon right
after the terminator. In this setup, ribosome can begin with the translation of
the leader region only when the RBS is in the ’on’ state. When this is the case,
the transcriptional-translational coupling occurs, i.e. the transcribing RNAP is
tightly followed by the translating ribosome. When the RNAP encounters the in-
trinsic terminator, it is not affected, because the translating ribosome pushes the
RNAP through the terminator sequence, not allowing RNAP to unbound. After
the RNAP is safely after the terminator, the ribosome leaves at the stop codon.
Therefore, the translational control element in the leader region is able to
control the transcription of the genes located downstream of the terminator. The
mechanism is illustrated in Fig. 15. The are two advantages in comparison to the
adaptors from Liu et al.:
1. RNA elements in the leader region can be easily switched, without any need
for modifications to the existing sequences.
2. Since the whole leader region was engineered de novo, the transcription of
the downstream genes is not dependent on the levels of tryptophan available
in the cell, although these dependencies can be engineered by the selection
of the used codons.
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promoter RNA element terminator gfp terminator
RNAP
RNAP
Theophylline
Ribosome
Figure 15: Mechanism of action of our adaptors design. In this example, when
in the ‘off’ state (without theophylline), the translational riboswitch sequesters
the RBS, therefore ribosome cannot bind and help the RNAP to go through the
intrinsic terminator. In the ‘on’ state, the RBS is free and ribosomes interact with
the transcribing RNAPs, allowing them to continue.
4.3 Overview of the designed adaptors
As a proof of concept, two different adaptors were designed and synthesized:
1. Adaptor using a theophylline riboswitch 12.1 [38] as an RNA element se-
questering the RBS. Upon binding of a theophylline molecule, RBS is freed
and ribosome can bound (see Fig. 15).
2. Adaptor using an RNA hairpin loop to sequester the RBS [39]. In the
opposite direction, on the same plasmid, a trans-acting RNA (taRNA) is
being produced under the control of a LacI promoter, which is repressed by
a LacI proteins in default. Upon the IPTG induction, taRNA is produced.
This taRNA interacts with the RNA hairpin loop in the adaptor, forces it
to change its conformation and expose the RBS (see Fig. 16).
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p1 RNA element terminator gfp terminator
RNAP
RNAP
Ribosome
Figure 16: Mechanism of action of our adaptor with the RNA hairpin loop. In the
default state, the hairpin loop is formed (blue) and RBS is sequestered. Upon the
interaction with taRNA, produced by the promoter p2, the secondary structure
changes and RBS is exposed.
Note that both these adaptors are positively regulated by the ligand (theo-
phylline) or by the taRNA. This would correspond to a positive feedback loop.
However, this could be easily changed by the use or design of different elements
for translational control. We have chosen these two examples because both used
RNA elements have been already experimentally tested in their native roles. This
minimized the chance of a failure due to the conformational changes of the RNA
elements.
4.4 Mathematical model
Before experiments, a set of ODEs was developed in order to capture the main
properties of the adaptors designed:
dS
dt
= CPm(1− Tp)− (kdr + µ)S, (16)
dM
dt
= CPmTp − (kdm + µ)M, (17)
dP
dt
= rM
m
m+ µ+ kdp
− (kdp + µ)M. (18)
Equation (16) stands for the production of a short RNA (i.e. RNA produced
when the transcribing RNAP ends at the intrinsic terminator), equation (17) for
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the production of mRNA (i.e. RNA which transcribed the coding gene) and
finally, equation (18) for the production of a protein from the produced mRNA.
Note the term Tp, which is a function defined as
Tp = f(KRBS, Lig, Tmax) = TmaxKRBS
Lig
K + Lig
+ (1− Tmax), (19)
where Tmax is the intrinsic terminator efficiency, KRBS is the relative strength of
the RBS used in the RNA element, and Lig is a ligand concentration.
The above equations can be used directly for the adaptor with the theophylline
riboswitch. For the adaptor with the hairpin loop, we must take into account the
production of the taRNA:
dT
dt
= CPta − (kdt + µ)T, (20)
where Pta is the transcription rate that depends on the concentration of the IPTG
and LacI repressor proteins:
Pta = P
0
ta
1 + 1
f
(
L
KL
(
1+ IPTG
KI
)
)nl
1 +
(
L
KL
(
1+ IPTG
KI
)
)nl . (21)
Then, the value of T can be used in the (19) as the ligand concentration Lig.
Values and descriptions of all the used parameters can be found in Appendix B.
5 Simulations and experimental validation
In this section the above formulated model is characterized through simulation.
Experimental data supporting the validity of the model is then presented.
5.1 Model simulations
The model with a theophylline riboswitch (Equations 16-18) was simulated to ver-
ify that it generates the expected behavior. The second model is an extension bof
the first and hence its simulation is here omitted. Also note, zero induction of the
RNA device cannot be achieved by the second model due to a basal transcription
of taRNA.
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First, the effects of the ligand (theophylline) concentration on the protein
expression with for a fixed (maximal) relative RBS strength were characterised:
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Figure 17: Protein concentration as a function of time and ligand concentration.
Results from our model for the adaptor with the theophylline riboswitch.
Figure 17 shows the expected behavior. Zero ligand concentration resulted in
minimal protein (GFP) concentration. This can be attributed to the terminator
efficiency, which is around 88%. When the ligand concentration increases, the
protein concentration also goes up, reaching a maximum at the maximal ligand
concentration. Further increasing of the ligand concentration doesn’t have any
significant effect on the protein concentration, suggesting that the transcription
rate is almost maximal at the ligand concentration of 2000μM. This corresponds
to a situation when all riboswitches (in case of multiple plasmids) are already in
the ‘on’ state.
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Figure 18: Protein concentration as a function of time and relative RBS strength.
Ligand concentration was set to zero.
Second, we explored the model behavior with no ligand present. When no
ligands are present, varying the RBS strength in the RNA element shouldn’t have
any impact on the protein expression (since the RBS is sequestered). The same
protein expression, corresponding to the basal level of transcription should be seen
for all values of KRBS. This was also confirmed (see Fig. 18).
Finally, the relationship between the ligand concentration and relative RBS
strength was investigated. For the same non-zero values of the ligand concentra-
tion, the protein steady-state concentration should be increasing with increasing
RBS strength. The model behavior corresponds to this assumption, as shown in
Figure 19.
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Figure 19: Steady-state protein concentration as a function of ligand concentration
and relative RBS strength.
5.2 Experimental validation
A set of experiments was proposed to validate the results obtained from the sim-
ulations. A plasmid contaning the adaptor with a harpin loop (see Sec. 4.3) was
transformed into E. coli cells. Transformed colonies were incubated overnight in
the LB media with the appropriate antibiotic. After the overnight incubation,
cultures were diluted into M9 media and transferred to a plate for fluorescence
and absorbance measurements.
Three different concentrations of the inducer of the promoter p2 (IPTG) were
tested, each in three replicates. These concentrations were chosen in order to
achieve: zero induction (no IPTG), full induction (1mM IPTG) and partial (50%)
induction (20μM IPTG). Measurements were taken every 10 minutes, for 200
minutes in total.
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Figure 20: Results from experimental characterization. Mean value of CNF for
all replicates is shown together with the standard deviation.
Resulting plot is shown in Fig. 20, where CNF is the Corrected Normalized
Fluorescence, which was calculated for every sample as follows:
CNF (t) =
F (t)− Fm
A(t)− Am − Fc, (22)
where F (t) is the measured fluorescence at time t, Fm is the fluorescence of the
M9 media, A(t) is the measured absorbance at 600nm, Am is the absorbance of
M9 media and Fc is the average normalized natural fluorescence of the cells.
The results validate the hypothesis. Fully induced cells had the highest value
of CNF for the duration of the experiment and cells with no induction maintained
the lowest value of CNF. The CNF for all the three cases exhibited a decreasing
trend with time. This is probably caused by the transfer of cells into M9 media
from LB media. M9 media is minimal (i.e., contains only essential nutrients).
Hence cells transferred from the optimal LB media to M9 media have a higher
metabolic burden in producing other metabolites and thereby have a decreased
capacity for expression of the transfected plasmid.
The transient phase hindered the validation of the dynamic characteristics of
our model. New experiments are planned using prolonged incubation after the
transfer from LB media to M9.
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6 Discussion and future work
6.1 Analysis of the trp operon
In this work, the tryptophan biosynthetic pathway and the underlying operon
were analysed using a developed physically relevant model. The roles of the im-
plemented regulatory mechanisms were elucidated in terms in terms of structure
and controller input. In addition to these mechanisms, alternatives from the field
of synthetic biology were proposed, with a special focus on their programmability.
6.2 Engineering operon regulation, adaptors design
We showed that controller inputs based on metabolite measurements can outper-
form the controller inputs based on enzyme measurements and that transcrip-
tional regulation is advantageous in the regulation of large operons. To address
challenges of rational design of transcriptional regulation based on metabolite
measurements, we proposed a novel mechanism motivated by easily designable ele-
ments from translational regulation. These adaptors use transcriptional-translational
coupling in prokaryotes and are potentially scalable to more larger logic circuits.
6.3 Simulations and experiments
A general deterministic model was proposed in order to capture the behavior
of the designed devices. In order to validate the proposed model, experimental
characterization of one of the constructs was performed. Steady state predictions
matched live cell measurements. Dynamic predictions remain to be tested.
6.4 Future work
In future work, new adaptors, using different RNA regulatory elements will be
designed and synthesized in order to investigate their characteristics. Proposed
elements include aptazymes, ribozymes and different types of rationally engineered
RNA hairpin loops. The role of other structures and their properties in the de-
signed leader region (RBS, intrinsic terminator) will be also evaluated.
Through a combined model based and evidence based design approach, the
future ambition is to build on the regulatory concepts developed in this thesis to
alleviate outstanding issues in future biotechnologies.
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A trp operon model parameters
Parameter Description Value
k1 Free operator synthesis rate 50 min
−1
k2 Transcription rate 5.1 min
−1
k3 Translation rate 20 min
−1
k4 Tryptophan synthesis rate 59 min
−1
kd1 Free operator degradation rate 0.5 min
−1
kd2 mRNA degradation rate 0.96 min
−1
kd3 Enzyme degradation rate 0 min
−1
K1 Repression’s dissociation constant 3.53 µM
K2 Attenuation’s dissociation constant 0.04 µM
K3 Enzyme inhibition’s dissociation constant 4.1 µM
n1 Repression’s Hill coefficient 1.92
n2 Attenuation’s Hill coefficient 1.72
n3 Enzyme inhibition’s Hill coefficient 1.2
g Tryptophan uptake kinetic rate 25 µMmin−1
Kg Tryptophan uptake’s dissociation constant 0.2 µM
Ot Total operator concentration 0.00332µM
µ Cell growth rate 0.01 min−1
d Tryptophan adsorption constant 23.5 µMmin−1
e Parameter in the Trp intake expression 0.9 µM
f Parameter in the Trp intake expression 380 µM
B Adaptor model parameters
Parameter Description Value
C Plasmid copy number 1
Pm Transcription rate 3 min
−1
kdr Short RNA degradation rate 0.3 min
−1
µ Cell growth rate 0.01 min−1
kdm mRNA degradation rate 0.96 min
−1
r Translation rate 50 min−1
m Protein maturation rate 0.05 min−1
kdp Protein degradation rate 0.035 min
−1
K Dissociation constant 300 µM
kdt taRNA degradation rate 0.3 min
−1
P 0ta Maximal transcription rate 3 min
−1
f LacI repression fold 1000
L LacI concentration 50 nM
KL LacI effective binding coefficient 50 µM
KI IPTG effective binding coefficient 400 µM
nl Hill coefficient 2

